Belite Bio (BLTE)
(Delayed Data from NSDQ)
$70.20 USD
-3.05 (-4.16%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $70.38 +0.18 (0.26%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Belite Bio, Inc. Sponsored ADR has a market cap of $2.33B, which represents its share price of $73.25 multiplied by its outstanding shares number of 31.84M. As a mid-cap company, BLTE's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BLTE 70.20 -3.05(-4.16%)
Will BLTE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BLTE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLTE
New Strong Sell Stocks for August 4th
New Strong Sell Stocks for July 22nd
BLTE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BLTE
BLTE forms Stochastic Reached Overbought on September 19
Shooting Star Candlestick appears for BLTE after 0.34% move
Upper Bollinger Band Walk appears for BLTE after 9.12% move
20 Day Moving Average Support appears for BLTE after 0.15% move
BLTE forms Bearish Engulfing on September 15